052260.KQ HYUNDAI BIOLAND Co.Ltd

Consumer Non-Cyclicals Personal Care Products KOSDAQ
8,150 KRW
Close of Oct 30, 2026
3,125 6,240
Market cap
KRW 122B
P/E
-
P/B
0.84x
ROE
15.4%
Dividend yield
1.72%
Fundamental score
1.6/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 052260.KQ undervalued?

Graham number

The Graham number of HYUNDAI BIOLAND Co.Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

HYUNDAI BIOLAND Co.Ltd fundamental analysis

9 of 22 checks passed

ROE 1/2

Moderate return on equity (15.4%), between 10% and 20%.

ROA 1/1

Return on assets (13.4%) is above the industry median (1.3%).

Profit Consistency 1/2

Profitable for 4 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 0/1

Not enough positive earnings history to compare last year's growth with the 5-year average.

Earnings Growth vs Industry 0/1

Last year's EPS growth (-95.6%) is below the industry median (-73.4%).

Revenue Growth 1/2

Revenue grew 9.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

No interest expense reported.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 0/1

Price to book (0.8x) is above the industry median (0.7x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 1/2

Dividend yield (1.7%) is above the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

Payout ratio is 831.3%, above 90% of earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

HYUNDAI BIOLAND Co.Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About HYUNDAI BIOLAND Co.Ltd

HYUNDAI BIOLAND Co.,Ltd manufactures and sells raw materials for cosmetics, nutraceuticals, and regenerative medicines. It offers anti-aging, moisturizing, whitening, skin protection, and other cosmetic ingredients; functional food ingredients and general food raw materials; and active pharmaceutical ingredients. The company was formerly known as SKbioland Co., Ltd. and changed its name to HYUNDAI BIOLAND Co.,Ltd in October 2020. HYUNDAI BIOLAND Co.,Ltd was incorporated in 1…

Full company profile